Rarres1通过NF-κB信号通路促进肾小球疾病进展
研究鉴定Rarres1为健康肾脏足细胞富集蛋白,在IgA肾病、糖尿病肾病及ANCA相关血管炎中肾小球和管周毛细血管内皮细胞Rarres1表达诱导。内皮细胞过表达Rarres1促进肾小球肾炎模型肾损伤进展,而内皮细胞敲除部分保护,机制为通过Axl激活NF-κB信号通路促进炎症和纤维化。
要点
- Rarres1在多种人类肾小球病内皮细胞中诱导表达,是慢性肾脏病常见分子机制。
- 内皮细胞Rarres1过表达促进肾小球肾炎肾损伤进展,敲除部分保护。
- Rarres1通过Axl激活NF-κB信号通路驱动炎症和纤维化。
核心结论
- 内皮细胞Rarres1表达诱导是常见人类肾小球病分子机制,通过NF-κB通路驱动炎症和纤维化,具致病作用。
研究设计与样本
- 研究使用足细胞特异性敲除小鼠、内皮细胞特异性条件敲入和敲除小鼠,结合公共RNA数据集分析。
主要发现
- 足细胞特异性敲除Rarres1不影响肾小球滤过屏障正常发育或维持,也不调节肾小球肾炎模型结局。
- IgA肾病、糖尿病肾病及ANCA相关血管炎中肾小球和管周毛细血管内皮细胞Rarres1表达诱导。
- 公共RNA数据集显示Rarres1表达诱导是慢性肾脏病常见分子机制。
- 内皮细胞过表达Rarres1不引起明显肾脏表型,但促进肾小球肾炎模型肾损伤进展;内皮细胞敲除部分保护。
- Rarres1通过激活受体酪氨酸激酶Axl,经转录因子NF-κB信号通路促进炎症和纤维化。
临床怎么用
- Rarres1及其下游Axl-NF-κB通路可能作为肾小球疾病抗炎抗纤维化治疗的潜在靶点。
局限性
- 机制和干预效果主要基于动物模型,人类肾小球病中的直接因果证据和临床转化价值尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inflammatory pathways are activated in most glomerular diseases but molecular mechanisms driving them in kidney tissue are poorly known. We identified retinoic acid receptor responder 1 (Rarres1) as a highly podocyte-enriched protein in healthy kidneys. Studies in podocyte-specific knockout animals indicated that Rarres1 was not needed for the normal development or maintenance of the glomerulus filtration barrier and did not modulate the outcome of kidney disease in a model of glomerulonephritis. Interestingly, we detected an induction of Rarres1 expression in glomerular and peritubular capillary endothelial cells in IgA and diabetic kidney disease, as well as in ANCA-associated vasculitis. Analysis of publicly available RNA data sets showed that the induction of Rarres1 expression was a common molecular mechanism in chronic kidney diseases. A conditional knock-in mouse line, overexpressing Rarres1 specifically in endothelial cells, did not show any obvious kidney phenotype. However, the overexpression promoted the progression of kidney damage in a model of glomerulonephritis. In line with this, conditional knock-out mice, lacking Rarres1 in endothelial cells, were partially protected in the disease model. Mechanistically, Rarres1 promoted inflammation and fibrosis via transcription factor Nuclear Factor-κB signaling pathway by activating receptor tyrosine kinase Axl. Thus, induction of Rarres1 expression in endothelial cells is a prevalent molecular mechanism in human glomerulopathies and this seems to have a pathogenic role in driving inflammation and fibrosis via the Nuclear Factor-κB signaling pathway.
引用
- Möller-Hackbarth K, Dabaghie D, Charrin E, et al. Retinoic acid receptor responder1 promotes development of glomerular diseases via the Nuclear Factor-κB signaling pathway. Kidney Int. 2021. PMID: 34147551. doi:10.1016/j.kint.2021.05.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。